x
0

Regeneron Pharmaceuticals Inc (REGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Regeneron Pharma's earnings

Delivery

Website notifications

Mobile App notifications

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
458.24 -3.13    -0.68%
24/05 - Closed. Currency in USD ( Disclaimer )
After Hours
451.80
-6.44
-1.41%
24/05
Type: Equity
Market: United States
ISIN: US75886F1075 
CUSIP: 75886F107
  • Volume: 468,844
  • Bid/Ask: 430.00 / 464.00
  • Day's Range: 452.11 - 461.94
Start Trading
Regeneron Pharma 458.24 -3.13 -0.68%

REGN Overview

 
Information about the Regeneron Pharmaceuticals Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close461.37
Day's Range452.11 - 461.94
Revenue4.98B
Open461.37
52 wk Range325.35 - 464.4
EPS8.31
Volume468,844
Market Cap49.04B
Dividend (Yield)0 (N/A)
Average Vol. (3m)767,094
P/E Ratio55.51
Beta1.5
1-Year Change15.22%
Shares Outstanding106,290,608
Next Earnings DateAug 02, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Buy Buy Buy Buy
Technical Indicators Strong Sell Sell Sell Strong Buy Strong Buy
Summary Strong Sell Neutral Neutral Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Harami Bearish 15 Current
Harami Cross Bearish 15 Current
Completed Patterns
Advance Block Bearish 1W 1 May 14, 2017
Bullish Engulfing 5H 6 May 22, 2017 09:00AM
Three Inside Up 1H 7 May 23, 2017 03:00PM

Regeneron Pharmaceuticals Inc News & Analysis

Regeneron Pharmaceuticals Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 458.24 430.00 464.00 468,844 -0.68% USD 24/05  
  Switzerland 441.00 0.00 0.00 0 0.00% CHF 19/05  
  Berlin 410.87 408.44 409.53 0 -0.27% EUR 24/05  
  Munich 410.99 408.44 409.53 0 +0.56% EUR 24/05  
  Stuttgart 407.45 0.00 0.00 15 -0.74% EUR 24/05  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery

Website notifications

Mobile App notifications

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 153.34 154.17 152.67 -0.46 -0.30% 19.22M 24/05  
  Amazon.com 980.35 981.00 970.23 +8.81 +0.91% 2.46M 24/05  
  Alphabet Inc C 954.96 955.09 949.50 +6.14 +0.65% 1.03M 24/05  
  Tesla 310.22 311.00 305.40 +6.36 +2.09% 5.04M 24/05  
  NVIDIA 138.57 141.07 138.08 +1.54 +1.12% 20.43M 24/05  
  Alphabet 977.61 978.12 971.63 +7.06 +0.73% 1.14M 24/05  
  Facebook 150.04 150.23 148.42 +1.97 +1.33% 17.94M 24/05  
  AMD 10.890 11.060 10.710 0.000 0.00% 43.03M 24/05  
  Bank of America 23.36 23.47 23.22 -0.03 -0.13% 59.21M 24/05  
  United States Steel 20.55 21.93 20.43 +0.17 +0.83% 47.57M 24/05  

Regeneron Pharmaceuticals Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

5400

Equity Type

ORD

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
No Start Trading
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $1000 Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
0%
Bearish
100%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest REGN Comments

Theodoridis Thomas
Theodoridis Thomas Nov 12, 2015 5:43PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
its coming and its from the weekly graph. From the serious investors. I don`t bear any responsibility for any trading losses you might incur as a result of using this data .
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.